Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Get into bed shortly after injecting and let it work
a method for additional weight management in a subject in need thereof with a BMI 27 kg/m 2 and at least one weight-related comorbidity comprising: administer to said subject 2.5 mg once weekly tirzepatide dose, or a pharmaceutically acceptable salt thereof
Hypertriglyceridaemia is defined as fasting levels above 1.7 mmol/L (a threshold used in metabolic syndrome diagnosis), with marked elevation between approximately 2.3-9.9 mmol/L, severe elevation 10 mmol/L, and very severe elevation 20 mmol/L
For weight management specifically, the 0.5 mg dose is considered part of the titration phase rather than a therapeutic endpointthe target maintenance dose for obesity treatment is 2.4 mg weekly
US$ 25.34
US$ 27.69
US$ 22.98
